ARKG Holdings of NTRA
Natera
Natera, Inc. is a genetic testing and diagnostics company that specializes in developing non-invasive tests for prenatal screening, cancer detection, and organ transplant rejection. The company generates revenue by providing these cutting-edge diagnostic services to healthcare providers, laboratories, and patients, leveraging its innovative technology to deliver accurate and timely results.
Trades of NTRA in ARKG
The ten most recent trades of Natera in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Nov 08, 2024 | Buy | $905,024 | 2.11% | 0.07% |
| Aug 13, 2024 | Buy | $390,292 | 1.03% | 0.03% |
| Aug 12, 2024 | Buy | $531,219 | 1.46% | 0.04% |
| Aug 09, 2024 | Buy | $1,588,695 | 4.73% | 0.13% |
| Aug 05, 2024 | Buy | $861,929 | 3.04% | 0.07% |
| Aug 02, 2024 | Buy | $3,841,556 | 15.12% | 0.27% |
| Jul 15, 2024 | Buy | $1,931,952 | 7.16% | 0.14% |
| May 30, 2024 | Buy | $1,848,035 | 15.61% | 0.14% |
| May 29, 2024 | Buy | $970,483 | 9.01% | 0.07% |
| May 28, 2024 | Buy | $1,976,675 | 22.53% | 0.14% |